Skip to main content
Clinical Trials/NCT04886908
NCT04886908
Completed
Not Applicable

Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology

Brugmann University Hospital1 site in 1 country373 target enrollmentFebruary 9, 2021
ConditionsSkin Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin Cancer
Sponsor
Brugmann University Hospital
Enrollment
373
Locations
1
Primary Endpoint
Name of the department in which the patient is followed
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Skin cancers are the most common of all cancers. Their incidence has increased sharply over the decades.This increase in incidence partly reflects an aging population and behavioral patterns such as repeated exposure to the sun. Indeed, exposure to UV rays is the predominant factor involved in the pathogenesis of these tumors, hence the fact that they mainly develop in photo-exposed regions such as the cephalic extremity.

The objective of this study is to provide an epidemiological analysis of tumors in the populations of both CHU Brugmann and St Pierre hospitals.

Registry
clinicaltrials.gov
Start Date
February 9, 2021
End Date
July 28, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laurence Postelmans

Head of Opthalmology clinic

Brugmann University Hospital

Eligibility Criteria

Inclusion Criteria

  • Final diagnosis confirmed by pathological analysis, epidemiological and clinical information available from patients.

Exclusion Criteria

  • Patients who have expressed a refusal to access their medical file or incomplete data will not be taken into account.

Outcomes

Primary Outcomes

Name of the department in which the patient is followed

Time Frame: 5 minutes

Ophthalmology-CHU Brugmann hospital or Dermatology-CHU Brugmann hospital or Ophthalmology- CHU St Pierre Hospital or Dermatology-CHU St Pierre Hospital

Laterality

Time Frame: 5 minutes

Laterality: left, right, median

Risk factor: solar exposition (yes/no)

Time Frame: 5 minutes

Lived in a sunny European country\> 1 year, lived in a sunny country outside Europe\> 1 year, sunbed use\> 1 session, history of solar erythema during childhood.

Histological diagnosis of the tumor

Time Frame: 5 minutes

Histological diagnosis of the tumor

Healthy or invaded margins

Time Frame: 5 minutes

Healthy or invaded margins

Tumor size

Time Frame: 5 minutes

Tumor size in millimeters

Risk factor: phototype

Time Frame: 5 minutes

Phototype 1 to 6 on the Fitzpatrick scale. The Fitzpatrick scale is a numerical classification schema for human skin color. Type 1 is pale skin that always burns, never tans and type 6 is deeply pigmented dark brown to darkest brown skin that never burns.

Surgical management method

Time Frame: 5 minutes

Biopsy resection, plasty, graft, second-line healing, enucleation, additional treatment: radiotherapy, immunotherapy, liquid nitrogen

Age

Time Frame: 5 minutes

Age of the patient at the time of diagnose

Multiple or single tumor

Time Frame: 5 minutes

Multiple or single tumor

Risk factor: immunosuppression (yes/no)

Time Frame: 5 minutes

Pathogenic or iatrogenic, history of malignant skin tumors other than melanoma, personal or family history of melanoma

Risk factor: keratosis

Time Frame: 5 minutes

Actinic keratosis of the face

Locoregional extension report (yes/no)

Time Frame: 5 minutes

Locoregional extension report (yes/no)

Superficial or infiltrating tumor

Time Frame: 5 minutes

Superficial or infiltrating tumor

Diagnostic method

Time Frame: 5 minutes

Diagnostic method: curettage, punch, biopsy, flattening

Tumor anatomical location

Time Frame: 5 minutes

Eyelids are distributed in their different regions: internal cantus and external cantus, upper eyelid and lower eyelid. Same for the face: ears, zygomatic, forehead, temples, cheeks, nose, upper lip, lower lip, chin, nasolabial fold, preauricular area, retroauricular area, brow bone.

Primitive tumor or recidive

Time Frame: 5 minutes

Primitive tumor or recidive

Diagnosis

Time Frame: 5 minutes

Time between the appearance of the tumor and the first consultation

Sex

Time Frame: 5 minutes

Sex of the patient

Study Sites (1)

Loading locations...

Similar Trials